SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Amprius Technologies, Inc. engages in the development, manufacture, and market lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the United States and Rest of the World geographical segments. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius Technologies is trending as a new U.S. manufacturing partnership with Nanotech Energy establishes a crucial domestic production pathway for its high-performance silicon anode batteries, particularly vital for defense and drone applications. The community is actively discussing the company's capital-light growth strategy and its potential for significant revenue expansion and profitability this year, further fueled by recent analyst upgrades.

The Cosmos network consists of many independent, parallel blockchains, called zones, each powered by classical Byzantine fault-tolerant (BFT) consensus protocols like Tendermint. Some zones act as hubs with respect to other zones, allowing many zones to interoperate through a shared hub. The architecture uses classic BFT and Proof-of-Stake algorithms, instead of Proof-of-Work. Cosmos can interoperate with multiple other applications and cryptocurrencies, something other blockchains can’t do well. By creating a new zone, you can plug any blockchain system into the Cosmos hub and pass tokens back and forth between those zones, without the need for an intermediary.  While the Cosmos Hub is a multi-asset distributed ledger, there is a special native token called the atom. ATOM have three use cases: as a spam-prevention mechanism, as staking tokens, and as a voting mechanism in governance.  As a spam prevention mechanism, ATOM are used to pay fees. The fee may be proportional to the amount of computation required by the transaction, similar to Ethereum’s concept of “gas”. Fee distribution is done in-protocol and a protocol specification is described here.  As staking tokens, ATOM can be “bonded” in order to earn block rewards. The economic security of the Cosmos Hub is a function of the amount of ATOM staked. The more ATOM that are collateralized, the more “skin” there is at stake and the higher the cost of attacking the network. Thus, the more ATOM there are bonded, the greater the economic security of the network.  Atom holders may govern the Cosmos Hub by voting on proposals with their staked ATOM.

Cosmos

Cosmos (ATOM) is a major talking point as its community actively discusses a significant tokenomics redesign, aiming to transition from inflationary rewards to a revenue-based model for enhanced value. This initiative, alongside its "Internet of Blockchains" vision and high staking yields, is being closely watched amidst evolving crypto market sentiment and anticipation of regulatory clarity.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is trending as the community discusses its recent launch of advanced GaN and SiC power platforms, crucial for improving efficiency in AI data centers and EV charging. Investors are keenly awaiting concrete contracts, especially in light of the company's strategic collaboration with NVIDIA, to demonstrate revenue realization from its high-performance power solutions.

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.

Seres Therapeutics Inc

Seres Therapeutics is trending following its decision to pause the SER-155 Phase 2 study and implement a significant workforce reduction, signaling a strategic shift towards earlier-stage programs and extending its cash runway. The market is reacting to this pivot, while the community actively discusses the implications for the company's future, with many debating if these moves position the company for an eventual buyout or if upcoming SER-155 irEC data will be the crucial catalyst for partnership.

Lockheed Martin Corp. is a global security and aerospace company, which engages in the research, design, development, manufacture, integration, and sustainment of technology systems, products, and services. It operates through the following business segments: Aeronautics, Missiles and Fire Control (MFC), Rotary and Mission Systems (RMS), and Space. The Aeronautics segment researches, designs, develops, manufactures, integrates, sustains, supports, and upgrades advanced military aircraft, including combat and air mobility aircraft, unmanned air vehicles, and related technologies. The MFC segment is involved in air and missile defense systems, tactical missiles and air-to-ground precision strike weapon systems, logistics, fire control systems, mission operations support, readiness, engineering support and integration services, manned and unmanned ground vehicles, and energy management solutions. The RMS segment designs, manufactures, services, and supports various military and commercial helicopters, surface ships, sea and land-based missile defense systems, radar systems, sea and air-based mission and combat systems, command and control mission solutions, cyber solutions, and simulation and training solutions. The Space segment includes the production of satellites, space transportation systems, and strategic, advanced strike, and defensive systems. The company was founded in 1995 and is headquartered in Bethesda, MD.

Lockheed Martin Corp.

Lockheed Martin is trending higher amid escalating global geopolitical tensions, particularly regarding potential US military action, which is driving investor expectations for increased defense spending and a strong rally in the defense sector. The company's recent positive earnings, optimistic guidance, and plans to significantly boost missile production are fueling community discussion and bullish sentiment despite its sharp price appreciation.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is trending following its selection as the first qualified vendor for the U.S. Army's Ground Vehicle Systems Center and renewed institutional interest. The community is actively discussing the company's critical role in defense and aerospace manufacturing, expecting significant growth and a potential short squeeze fueled by partnerships with entities like SpaceX and Anduril.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrow Health is trending as its Vevye product experiences surging prescription growth driven by major PBM formulary wins and an expanded sales force, with positive news around pipeline developments and regulatory resolutions fueling community discussions about significant revenue acceleration and potential short-covering.

Polygon

Polygon (POL) is trending as it cements its position as a foundational layer for regulated payments and Real-World Assets (RWAs) through significant acquisitions and surging stablecoin transaction volumes. The community remains actively engaged with its ongoing network upgrades, like the AggLayer, and proposed token burns, weighing these strong fundamentals against current market price action.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassian is trending due to a significant sell-off following strong earnings, sparking an intense community debate on whether the broader software sector faces an existential AI threat or if the stock represents a deeply undervalued buying opportunity.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is trending due to escalating speculation about a potential buyout by major tech players like SpaceX or Amazon, leveraging its uniquely valuable n53 spectrum and deepening Apple partnership for direct-to-device connectivity. The community eagerly anticipates key FCC decisions regarding spectrum use and the C-3 constellation, which are seen as critical catalysts to unlock the company's significant undervalued assets and emerging IoT solutions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sean Mcclain Sells 26,761 Shares of Absci (NASDAQ:ABSI) Stock

Absci Corporation (NASDAQ:ABSI - Get Free Report) CEO Sean Mcclain sold 26,761 shares of Absci stock in a transaction dated Monday, February 2nd. The shares were sold at an average price of $2.99...

Absci Corporation (NASDAQ:ABSI) Given Average Recommendation of "Moderate Buy" by Brokerages

Shares of Absci Corporation (NASDAQ:ABSI - Get Free Report) have received an average rating of "Moderate Buy" from the seven research firms that are presently covering the stock, Marketbeat reports...

Absci Unveils Origin-1 AI Model, Teases 2025 Hair-Loss Data and Q4 Endometriosis Trial Launch

Absci (NASDAQ:ABSI) used a presentation at the 44th JPMorgan Healthcare Conference to outline recent platform updates and provide a timeline for upcoming clinical data in androgenic alopecia and...

Absci (NASDAQ:ABSI) Shares Down 9.1% - Here's What Happened

Absci (NASDAQ:ABSI) Trading Down 9.1% - Should You Sell...

Absci Corporation (NASDAQ:ABSI) Given Consensus Rating of "Moderate Buy" by Brokerages

Shares of Absci Corporation (NASDAQ:ABSI - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the seven ratings firms that are presently covering the company...

Absci (NASDAQ:ABSI) Trading Down 4.2% - Here's What Happened

Absci (NASDAQ:ABSI) Trading Down 4.2% - Here's Why...

Absci (NASDAQ:ABSI) Trading Up 11.1% - Time to Buy?

Absci (NASDAQ:ABSI) Stock Price Up 11.1% - Still a Buy...

AI Creation Engines Transform Biotech as Wellness Tech Captures Growth Wave

AI Creation Engines Transform Biotech as Wellness Tech Captures Growth Wave AI Creation Engines Transform Biotech as Wellness Tech Captures Growth Wave PR Newswire VANCOUVER, BC, Dec. 12, 2025 Issued...

Absci (NASDAQ:ABSI) Receives "Buy" Rating from Needham & Company LLC

Needham & Company LLC restated a "buy" rating and set a $7.00 price target on shares of Absci in a research note on Friday...

Absci (NASDAQ:ABSI) Shares Gap Up - Should You Buy?

Absci (NASDAQ:ABSI) Shares Gap Up - Still a Buy...

Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech innovators to create the next generation of protein-based drugs. The company was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.

Absci Corp

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

ABSI
Absci Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ABSI News

ABSIAbsci Corp